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INTRODUCTION

DISCUSSION

STATUS OF RESEARCH

Research on the impacts of cardiopulmonary
disease on the lymphatic system has been gaining
traction as of late. Studies have revealed
exacerbation of cardiopulmonary disease that is
caused by lymphatic dysfunction and vice versa.
Various research hints at the possibility of targeting
the lymphatic system to ensure and maintain
cardiopulmonary function. By targeting the
lymphatic system, researchers hope to delay the
progression of cardiopulmonary failure exacerbated
by worsening lymphatic system function by
rescuing the lymphatic system. More research is
being conducted to investigate the impact of
cardiopulmonary disease on the lymphatic system
to find the extent of damage and the key players and
mechanism of action to reduce the pathological
progression of cardiopulmonary disease.

More studies should be followed to see the impact of
cardiopulmonary disease in not just the local
lymphatic node changes but the systemic changes
that may occur to the whole lymphatic system. In
particular, lymphatic vasculature and its dysfunction
can be a future study to complement the findings of
this research. Currently, radionuclide
lymphoscintigraphy using Technetium 99 injected
sub-dermally is a popular method for assessing
lymphatic function. Future research depicting the
change of lymphatic vasculature function in patients
with cardiopulmonary disease as opposed to those
who are not suffering from it may be interesting to
see for seeing the progression of lymphatic
dysfunction in diseased states. A time-dependent
change may help provide clues as to potentially
finding factors that may mitigate or lessen the
impact of diseased states has on lymphatic
dysfunction. A significant limitation to this approach
may be that it will only help assess the level of
Technetium uptake by lymphatics and its function,
but its poor resolution will not aid in seeing
anatomical changes lymphatic vessels may have
undergone. Future research will need
complementary methods if it aims to investigate the
exact mechanism contributing to its dysfunction.
Additionally, the potential of regulating lymphatic
vessels via targeting the autonomic nervous system
has not received as much attention. Researchers
confirmed that lymphatic endothelial cells are a
direct target of neurotransmitters and that there are
nerves closely associated with lymphatic vessels. A
study involving α1 – adrenergic and muscarinic
agents and its involvement with lymphatic vessel
contractility in vivo revealed its ability to modulate
lymphatic vessel function. Perhaps a study utilizing
the effect of α1 – adrenergic and muscarinic agents
and its effect in cardiopulmonary disease patients
can reveal potential therapeutic benefits.
Theoretically, improved contractility of lymphatic
vessels may help lessen the drainage burden and
improve the cardiopulmonary system's overall
function.

1) I am currently working on ways to meaningfully
analyze and depict data.
2) Troubleshooting histology sectioning and
tweaking protocol for processing of lymph node
tissue
3) Practicing staining of lymph node tissue to view
under microscope

OBJECTIVE
This research aimed to investigate the effect of
cardiopulmonary disease and its impact on the
lymphatic structure.
METHODS
A total of 9 cadavers were dissected for specific
regions of the body. The regions were: lumbar,
common iliac, sacral, internal iliac, external iliac,
deep inguinal, superficial inguinal, pulmonary,
cardiac, parasternal, infraclavicular, central axillary,
pectoral, humeral, subscapular, anterior neck,
lateral neck, hepatic, kidney, supraclavicular,
gastric, diaphragmatic, submandibular, submucosal,
and internal jugular. Some regions were omitted
from analysis if they failed to meet the range of
nodes reported per body by various sources as it
may skew the statistical analysis. Statistical
analysis was performed utilizing GraphPad Prism 9.
The mean number of lymph nodes per region and
mean two-dimensional area of lymph nodes with or
without disease were compared. A one-tail twosample t-test was performed to see if
cardiopulmonary lymph nodes were statistically
larger than non-cardiopulmonary lymph nodes.
Lastly, histological analysis was performed to mark
any qualitative changes between lymph nodes with
or without the disease.
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